A scientific evaluate of VIP in experimental autoimmune encephalomyelitis (the MS model) discovered that VIP administration reduced clinical severity scores by 40–65% throughout twelve impartial scientific tests, with histological Examination displaying lessened CNS infiltration of Th1 and Th17 cell